# Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease

> **NCT03412513** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 144 (estimated)

## Conditions studied

- Overactive Bladder
- Parkinson Disease

## Interventions

- **DRUG:** Mirabegron
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03412513
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-17
- **Primary completion:** 2018-07-16
- **Final completion:** 2018-12-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03412513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03412513, "Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03412513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*